Defendant Name: J. Michael Pearson

Defendant Type: Individual

Initial Case Details

Legal Case Name In the Matter of J. Michael Pearson
First Document Date 31-Jul-2020
Initial Filing Format Administrative Action
File Number 3-19900
Allegation Type Issuer Reporting and Disclosure
AAER 4154

Affiliations

Violations Alleged

Securities Act
• Sec 17(a)(2)
• Sec 17(a)(3)
Other
• Sec 304(a) Sarbanes-Oxley Act
• Rule 100(b) of Regulation G

Related Violations Alleged

J. Michael Pearson is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 12b-20 of the Exchange Act.
J. Michael Pearson is alleged to have caused Bausch Health Companies, Inc.'s violation of Sec 13(a) of the Exchange Act.
J. Michael Pearson is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 13a-1 of the Exchange Act.
J. Michael Pearson is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 13a-11 of the Exchange Act.
J. Michael Pearson is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 13a-13 of the Exchange Act.
J. Michael Pearson is alleged to have caused Bausch Health Companies, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act.

Resolutions

First Resolution Date 31-Jul-2020
Headline Total Penalty and Disgorgement

See Related Documents

Related Documents:

33-10810 31-Jul-2020 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933 and Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order

Related Actions:

In the Matter of Valeant Pharmaceuticals International, Inc., n/k/a Bausch Health Companies Inc.
Bausch Health Companies, Inc.
In the Matter of Howard B. Schiller
Howard B. Schiller
In the Matter of Tanya R. Carro, CPA
Tanya R. Carro, CPA